District neighboring Hong Kong attracts global investment for commerce, trade, and cultural tourismby December 10, 2024PR Newswire
Live from ASH 2024 | First Dataset of Olverembatinib in Combination with Bcl-2 Inhibitor Lisaftoclax Demonstrates Potential Clinical Benefits as a Chemotherapy-Free Regimen for Children with R/R Ph+ ALLby December 10, 2024PR Newswire
Stellantis and CATL to Invest Up to €4.1 Billion in Joint Venture for Large-Scale LFP Battery Plant in Spainby December 10, 2024PR Newswire
State Grid Xuzhou Power Supply Company: Helping to boost the “green content” of industrial developmentby December 10, 2024PR Newswire
BingX Sponsors Taipei Blockchain Week for the Third Year, Driving Web3 Innovationby December 10, 2024PR Newswire
Bring Christmas Cheer to Your Home with Yaber Projectors: Holiday Sale Now Live on Amazonby December 10, 2024PR Newswire
Waters Highlights Continued Progress Towards Sustainability Commitmentsby December 10, 2024PR Newswire
Terumo Health Outcomes and Medis Medical Imaging Announce Strategic Partnership to Enhance Cardiovascular Careby December 10, 2024PR Newswire
Live from ASH 2024 | 1.5-Year Follow-Up Data from a Global Study of Olverembatinib Reaffirms Potential in Overcoming Resistance/Intolerance to Ponatinib or Asciminibby December 10, 2024PR Newswire
Live from ASH 2024 | First Dataset of Olverembatinib as Second-Line Therapy in Patients with Non-T315I-Mutant CP-CML Presented in Oral Reportby December 10, 2024PR Newswire
การบริจาคด้านสภาพภูมิอากาศเพิ่มขึ้น 20% ในปี 2566 แซงหน้าการเติบโตของการบริจาคเพื่อการกุศลทั่วโลกby December 10, 2024PR Newswire
The new battleground for commercial card providers: Rewards and flexibility, Ascenda report revealsby December 10, 2024PR Newswire
Live from ASH 2024 | Ascentage Pharma’s Bcl-2 Inhibitor Lisaftoclax in Combinations Demonstrates Potential Clinical Benefit in Patients with Prior Exposure to Venetoclaxby December 10, 2024PR Newswire
Live from ASH 2024 | 1.5-Year Follow-Up Data from a Global Study of Olverembatinib Reaffirms Potential in Overcoming Resistance/Intolerance to Ponatinib or Asciminibby December 10, 2024PR Newswire
Bybit Web3 Boosts its Supports to L1 Ecosystems at Taipei Blockchain Week 2024 with Co-hosted Solana and Sui Eventsby December 10, 2024PR Newswire
ST Engineering iDirect Releases Industry-first Breakthrough Multi-Orbit Capabilityby December 10, 2024PR Newswire
